| Literature DB >> 26485299 |
Bao Quoc Tran1, Christopher Barton2, Jinhua Feng2, Aimee Sandjong2, Sung Hwan Yoon1, Shivangi Awasthi1, Tao Liang1, Mohd M Khan1, David P A Kilgour1, David R Goodlett3, Young Ah Goo4.
Abstract
We employed top- and middle-down analyses with multiple fragmentation techniques including electron transfer dissociation (ETD), electron capture dissociation (ECD), and matrix-assisted laser desorption ionization in-source decay (MALDI-ISD) for characterization of a reference monoclonal antibody (mAb) IgG1 and a fusion IgG protein. Fourier transform ion cyclotron resonance (FT-ICR) or high performance liquid chromatography electrospray ionization (HPLC-ESI) on an Orbitrap was employed. These experiments provided a comprehensive view on the protein species; especially for different glycosylation level in these two proteins, which showed good agreement with oligosaccharide profiling. Top- and middle-down MS provided additional information regarding glycosylation sites and different combinational protein species that were not available from oligosaccharide mapping or conventional bottom-up analysis. Finally, incorporating a limited enzymatic digestion by immunoglobulin G-degrading enzyme of Streptococcus pyogene (IdeS) with MALDI-ISD analysis enabled extended sequence coverage of the internal region of protein without pre-fractionation. BIOLOGICAL SIGNIFICANCE: Oligosaccharide profiling together with top- and middle-down methods enabled: 1) detection of heterogeneous glycosylated protein species and sites in intact IgG1 and fusion proteins with high mass accuracy, 2) estimation of relative abundance levels of protein species in the sample, 3) confirmation of the protein termini structural information, and 4) improved sequence coverage by MALDI-ISD analysis for the internal regions of the proteins without sample pre-fractionation.Entities:
Keywords: Glycosylation; MALDI-ISD; Middle-down; Oligosaccharide profiling; Protein species; Top-down
Mesh:
Substances:
Year: 2015 PMID: 26485299 DOI: 10.1016/j.jprot.2015.10.021
Source DB: PubMed Journal: J Proteomics ISSN: 1874-3919 Impact factor: 4.044